Delivery Order 75N95021D00026-75N95024F00003

Award Date 3/15/24
Potential Completion Date 12/15/24
Potential Value $225K
Contracting Federal Agency
National Institute on Drug Abuse
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Chicago, IL 60616, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for $201,969.00 and was issued by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency, to the IIT Research Institute (IITRI), a non-profit subsidiary of the Illinois Institute of Technology. The contract is for non-GLP dose range finding (DRF) studies to be completed by December 2023. This appears to be a task order issued under IITRI's $174.5 million single-award Pharmacology and Toxicology for Therapeutics Program contract...
This is a $473,586.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS) to the IIT Research Institute (IITRI), a non-profit division of the Illinois Institute of Technology. The contract, which does not have a set-aside designation, is part of NINDS's Pharmacology and Toxicology for Therapeutics Program and supports preclinical research activities, including toxicology studies and safety assessments of potential...
This federal contract award to IIT Research Institute (IITRI), a non-profit division of the Illinois Institute of Technology, is for $212,495.00 under the National Institute of Neurological Disorders and Stroke's (NINDS) Pharmacology and Toxicology for Therapeutics Program. The contract, awarded on March 1, 2024, is a firm fixed-price delivery order that runs through September 12, 2026. IITRI has extensive experience supporting the Department of Health and Human Services through preclinical drug...
This federal contract award, valued at $698,236.00, was issued to the Illinois Institute of Technology Research Institute (IITRI), a non-profit organization, by a U.S. government agency. The contract is a Definitive Contract with a Firm Fixed Price pricing type. It does not have a set-aside designation. IITRI is a preclinical contract research organization (CRO) that provides a wide range of services to pharmaceutical, biotechnology, and government clients, including the National Institutes of...
This federal contract award was made by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health, to the IIT Research Institute (IITRI), a non-profit contract research organization. The $119,495.00 firm fixed-price Purchase Order is for a 14-day dose range finding study in mice to support Investigational New Drug (IND) applications. IITRI has extensive experience conducting preclinical drug development services, including toxicology,...
This federal contract award, valued at $33,483,214.15, was issued by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to the IIT Research Institute (IITRI), a non-profit contract research organization. The contract is for preclinical pharmacology and toxicology studies to support the development of small molecule, biologic, and RNA therapeutic candidates across various disease areas. IITRI has extensive experience providing these services to...
This is a delivery order awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to the IIT Research Institute (IITRI), a non-profit contract research organization. The $1,725 firm fixed price order is for a contract orientation meeting and is part of a larger $146.3 million IDIQ contract between IITRI and the National Institute of Allergy and Infectious Diseases (NIAID) for preclinical models of infectious diseases. IITRI has...
The National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $1,523 firm fixed price delivery order contract to IIT Research Institute of Chicago, Illinois. This order is against IIT Research Institute's indefinite-delivery/indefinite-quantity prime contract vehicle for the Pharmacology and Toxicology for Therapeutics Program, which provides research support services. The scope of work under this order involves a kickoff meeting to support the program's...
This is a $631,772.00 delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to the IIT Research Institute (IITRI), a non-profit contract research organization. The contract is for toxicology studies on reproductive effects in rats, supporting the NCCIH (National Center for Complementary and Integrative Health) program. This is a cost-plus-fixed-fee contract that was not set aside for any type of small...
This is a Cost Plus Fixed Fee contract awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services, to the IIT Research Institute (IITRI), a non-profit contract research organization. The $159,319,089.46 contract, which does not have a set-aside designation, is for preclinical toxicology and pharmacology studies to support Investigational New Drug (IND) applications for small molecule, biologic, and RNA therapeutic candidates across various...
  • 75N95021D00026
    Indefinite Delivery Contract
  • 75N95021D00026-75N95024F00003
    Delivery Order

This is a federal contract award issued by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency within the U.S. Department of Health and Human Services, to the IIT Research Institute (IITRI), a non-profit division of the Illinois Institute of Technology. The $224,716.00 contract is a delivery order under a larger indefinite delivery/indefinite quantity (IDIQ) vehicle called the Pharmacology and Toxicology for Therapeutics Program, which has a total ceiling value of $174.5 million. Under this delivery order, IITRI will conduct Department of Defense (DOD)-mandated Dose Range-Finding (DRF) studies. The contract does not have a set-aside designation. IITRI has extensive experience supporting the preclinical development of various therapeutic candidates, including for neurological disorders, through contracts and grants from federal agencies like NINDS, the National Cancer Institute, and the National Center for Advancing Translational Sciences.

Generated 9/6/24, 10:00 AM